Nomura Asset Management International »

Aeglea Biotherapeutics shares owned by Nomura Asset Management International

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Nomura Asset Management International from 13F filings

Historical chart of Nomura Asset Management International investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Nomura Asset Management International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Nomura Asset Management International

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 43k 88.78

More positions owned by Nomura Asset Management International

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Broadcom (AVGO)
Lam Research Corp Com New (LRCX)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Texas Instruments Incorporated (TXN)
Howmet Aerospace (HWM)
Visa Com Cl A (V)
Micron Technology (MU)

View all positions for Nomura Asset Management International

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics